Insider trade

Arcutis Biotherapeutics (ARQT)Director bought ~$35K

Patrick J Heron, Director at Arcutis Biotherapeutics, bought ~$35K of Arcutis Biotherapeutics shares.

~$35K
Approx. value · 2,646 sh @ $13.08: 27K
Holds after · shares reported

Traded: Jun 13, 2025
Filed: Jun 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

May 1, 2025InsiderDirector sold ~$146K of ARQT shares in the open market
May 2, 2025Insider · 3 peopleInsiders: 3 sales (~$290K)
May 8, 2025InsiderOfficer sold ~$53K of ARQT shares in the open market
May 9, 2025InsiderDirector purchased ~$86K of ARQT shares in the open market
May 13, 2025InsiderDirector purchased ~$33K of ARQT shares in the open market
May 14, 2025InsiderDirector purchased ~$87K of ARQT shares in the open market
May 15, 2025InsiderDirector purchased ~$34K of ARQT shares in the open market
May 19, 2025InsiderOfficer sold ~$105K of ARQT shares in the open market
May 21, 2025InsiderDirector purchased ~$34K of ARQT shares in the open market
May 22, 2025InsiderDirector purchased ~$34K of ARQT shares in the open market
May 28, 2025InsiderOfficer sold ~$25K of ARQT shares in the open market
Jun 4, 2025InsiderDirector purchased ~$25K of ARQT shares in the open market
Jun 5, 2025InsiderDirector purchased ~$5.1K of ARQT shares in the open market
Jun 13, 2025 · this disclosureInsiderDirector purchased ~$35K of ARQT shares in the open market

What came next

Jun 18, 2025InsiderDirector sold ~$136K of ARQT shares in the open market
Jul 1, 2025InsiderDirector sold ~$127K of ARQT shares in the open market
Jul 10, 2025InsiderOfficer sold ~$346K of ARQT shares in the open market
Jul 14, 2025InsiderOfficer sold ~$87K of ARQT shares in the open market
Aug 1, 2025Insider · 1 personInsiders: 2 sales (~$143K)
Aug 4, 2025Insider · 4 peopleInsiders: 4 sales (~$295K)
Aug 8, 2025InsiderOfficer sold ~$54K of ARQT shares in the open market
Aug 19, 2025InsiderOfficer sold ~$28K of ARQT shares in the open market
Aug 21, 2025InsiderOfficer sold ~$38K of ARQT shares in the open market
Sep 2, 2025InsiderDirector sold ~$156K of ARQT shares in the open market
Sep 4, 2025InsiderOfficer sold ~$584K of ARQT shares in the open market
Sep 8, 2025InsiderDirector sold ~$169K of ARQT shares in the open market
Sep 9, 2025InsiderDirector sold ~$8.8K of ARQT shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Arcutis Biotherapeutics

For Arcutis Biotherapeutics, OQRO holds 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ARQT page.

Other recent filings by Patrick J Heron, Director

The full history of Patrick J Heron, Director is on the profile page.

How this filing works

Other disclosures at Arcutis Biotherapeutics

Everything OQRO holds on this company is on its ARQT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data